|
PD-L1/VEGF Bispecific Antibody Clinical Trials
1 actively recruiting trial
Pipeline
Phase 3: 1
Top Sponsors
- Shanghai Pulmonary Hospital, Shanghai, China1
Indications
- Locally Advanced Non-Small Cell Lung Cancer1
- Lung Cancer1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.